Chapter 9. LangChain for Medicine and Healthcare
The leaders of prominent AI companies, including Sam Altman of OpenAI, Demis Hassabis of Google DeepMind, and Dario Amodei of Anthropic, have voiced strong convictions about the transformative potential of their AI technologies within the medical field.
The past few chapters have explored how generative AI transforms research, biology, chemistry, and drug discovery. As big data expanded, major tech companies—such as Google, Microsoft, and IBM—began investing heavily in healthcare, leveraging AI to enhance medical diagnostics, patient management, and overall healthcare system efficiency. Early successes included AI-driven medical imaging, predictive disease progression analytics, and automated workflows in hospitals. Today, generative AI continues to push the boundaries of innovation in drug discovery and personalized medicine.
Google has been a leader in applying AI to medicine through its AI research division, DeepMind, and health-focused initiatives. Google Health has worked on AI-powered tools for medical imaging and electronic health records (EHRs), while DeepMind has made groundbreaking advances in protein structure prediction with AlphaFold. In 2021, Google acquired Fitbit for $2.1 billion, strengthening its position in wearable health technology and AI-driven personal health data insights.
Apple, too, has entered the health space through devices like the Apple Watch, which, starting from Series 4, has ECG capabilities that ...
Become an O’Reilly member and get unlimited access to this title plus top books and audiobooks from O’Reilly and nearly 200 top publishers, thousands of courses curated by job role, 150+ live events each month,
and much more.
Read now
Unlock full access